Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,950	93 Pages	BIS Research	January, 2024	BIS18455824

Best Price Guarantee
Price	from $2,950
Length	93 Pages
Publisher	BIS Research
Published Date	January, 2024
SKU	BIS18455824

Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032

Introduction to Europe Gene Editing Technologies Market

The Europe gene editing technologies market was valued at $0.37 billion in 2023 and is anticipated to reach $3.26 billion by 2032, witnessing a CAGR of 27.24% during the forecast period 2023-2032. The gene editing technologies market is anticipated to experience growth primarily due to the rising demand for personalized medicine. Furthermore, the introduction of novel technologies has further propelled the expansion of this market.

Market Introduction

The European gene editing technologies market is experiencing notable growth driven by the increasing demand for personalized medicine and the introduction of advanced technologies. Gene editing techniques are gaining prominence for their potential in tailoring medical treatments to individual patients, offering more effective therapies. Additionally, the emergence of novel gene editing technologies is enhancing precision and efficiency, making them increasingly valuable for research and clinical applications in Europe. The region's robust commitment to scientific research, biotechnology, and supportive regulatory frameworks creates a conducive environment for gene editing technology adoption. Ethical and responsible gene editing practices further ensure sustainable growth in this market. As gene editing continues to transform healthcare and life sciences, the European gene editing technologies market presents promising opportunities for scientific progress and therapeutic innovation.

Market Segmentation:

Segmentation 1: by Technology

CRISPR Gene Editing Technology
Non-CRISPR Gene Editing Technology

Segmentation 2: by Application

Agriculture
Biomedical

Segmentation 3: by Country

Germany
U.K.
France
Italy
Spain
Switzerland
Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The gene editing technologies market (by technology) has been segmented into CRISPR gene editing technology and non-CRISPR gene editing technology. Moreover, the study provides the reader with a detailed understanding of the different applications of gene editing technologies in agricultural and biomedical.

Growth/Marketing Strategy: Gene editing technologies are being used for agricultural, biomedical, and other applications. Various companies are providing gene editing products and services, which is also the key strategy for market players to excel in the current gene editing technologies market.

Competitive Strategy: Key players in the Europe gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Companies Profiled

BRAIN Biotech AG
Cellectis S.A.
CRISPR Therapeutics AG
DNA Script
Magento, Inc.
Merck KGaA

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 1-5 business days to complete the report upon order confirmation.

Executive Summary
1 Product Definition: 1.1 Inclusion and Exclusion Criteria
2 Market Scope: 2.1 Key Questions Answered in the Report
3 Research Methodology
4 Market Overview: 4.1 Market Overview; 4.2 Market Footprint and Potential Growth Scenario; 4.2.1 Realistic Growth Scenario; 4.2.2 Optimistic Growth Scenario; 4.2.3 Pessimistic Growth Scenario; 4.3 Evolution of Gene Editing Technologies; 4.4 Clinical Trials
5 Industry Outlook: 5.1 Regulatory Landscape; 5.1.1 Marketing Authorization; 5.1.2 USFDA Guidelines for BLA Submission; 5.1.3 Post-Authorization Regulations; 5.2 Legal Requirements and Frameworks in Europe; 5.2.1 EMA Biologics License Application Process; 5.2.2 Centralized Procedure; 5.2.3 Decentralized Procedure; 5.2.4 Mutual-Recognition Procedure; 5.2.5 National Procedure; 5.3 Expedited Regulatory Designations Around the World; 5.4 Product Benchmarking; 5.4.1 Product Benchmarking (by Technology); 5.4.2 Comparative Analysis; 5.5 Technology Adoption Matrix; 5.6 Industry Trends; 5.6.1 Leveraging Collaboration as a Major Key Strategies to Create Opportunities for Gene Editing Technologies; 5.6.2 Growing Focus on Gene Therapies; 5.7 Patent Analysis; 5.7.1 Patent Analysis (by Year); 5.7.2 Patent Analysis (by Technology); 5.7.3 Patent Analysis (by Region); 5.7.4 Patent Analysis (by Country)
6 Europe: 6.1 Overview; 6.2 Europe; 6.2.1 Europe Gene Editing Technologies Market (by Application); 6.2.2 Europe Gene Editing Technologies Market (by Technology); 6.2.3 Europe Gene Editing Technologies Market (by Country); 6.2.3.1 Germany; 6.2.3.1.1 Germany Gene Editing Technologies Market (by Application); 6.2.3.1.2 Germany Gene Editing Technologies Market (by Technology); 6.2.3.2 U.K.; 6.2.3.2.1 U.K. Gene Editing Technologies Market (by Application); 6.2.3.2.2 U.K. Gene Editing Technologies Market (by Technology); 6.2.3.3 Switzerland; 6.2.3.3.1 Switzerland Gene Editing Technologies Market (by Application); 6.2.3.3.2 Switzerland Gene Editing Technologies Market (by Technology); 6.2.3.4 France; 6.2.3.4.1 France Gene Editing Technologies Market (by Application); 6.2.3.4.2 France Gene Editing Technologies Market (by Technology); 6.2.3.5 Spain; 6.2.3.5.1 Spain Gene Editing Technologies Market (by Application); 6.2.3.5.2 Spain Gene Editing Technologies Market (by Technology); 6.2.3.6 Italy; 6.2.3.6.1 Italy Gene Editing Technologies Market (by Application); 6.2.3.6.2 Italy Gene Editing Technologies Market (by Technology); 6.2.3.7 Rest-of-Europe; 6.2.3.7.1 Rest-of-Europe Gene Editing Technologies Market (by Application); 6.2.3.7.2 Rest-of-Europe Gene Editing Technologies Market (by Technology)
7 Company Profiles: 7.1 BRAIN Biotech AG; 7.1.1 Company Overview; 7.1.2 Role of BRAIN Biotech AG in the Gene Editing Technologies Market; 7.1.3 Major Product: Key Specifications; 7.1.4 Key Competitors; 7.1.5 Financials; 7.1.6 Key Insights about the Financial Health of the Company; 7.1.7 Analyst Perspective; 7.2 Cellectis S.A.; 7.2.1 Company Overview; 7.2.2 Role of Cellectis S.A. in the Gene Editing Technologies Market; 7.2.3 Major Product: Key Specifications; 7.2.4 Key Competitors; 7.2.5 Financials; 7.2.6 Key Insights about the Financial Health of the Company; 7.2.7 Analyst Perspective; 7.3 CRISPR Therapeutics AG; 7.3.1 Company Overview; 7.3.2 Role of CRISPR Therapeutics AG in the Gene Editing Technologies Market; 7.3.3 Major Product: Key Specifications; 7.3.4 Key Competitors; 7.3.5 Financials; 7.3.6 Key Insights about the Financial Health of the Company; 7.3.7 Analyst Perspective; 7.4 DNA Script; 7.4.1 Company Overview; 7.4.2 Role of DNA Script in the Gene Editing Technologies Market; 7.4.3 Major Products: Key Specifications; 7.4.4 Key Competitors; 7.4.5 Analyst Perspective; 7.5 Magento, Inc.; 7.5.1 Company Overview; 7.5.2 Role of Magento, Inc. in the Gene Editing Technologies Market; 7.5.3 Major Products: Key Specifications; 7.5.4 Key Competitors; 7.5.5 Analyst Perspective; 7.6 Merck KGaA; 7.6.1 Company Overview; 7.6.2 Role of Merck KGaA in the Gene Editing Technologies Market; 7.6.3 Major Products: Key Specifications; 7.6.4 Key Competitors; 7.6.5 Financials; 7.6.6 Key Insights about the Financial Health of the Company; 7.6.7 Analyst Perspective
List of Figures: Figure 1: Europe Gene Editing Technologies Market, $Billion, 2022-2032; Figure 2: Europe Gene Editing Technologies Market: Drivers, Restraints, and Opportunities; Figure 3: Gene Editing Technologies Market (by Technology), $Billion, 2022-2032; Figure 4: Europe Gene Editing Technologies Market (by Application), $Billion, 2022-2032; Figure 5: Gene Editing Technologies Market (by Region), $Billion, 2022 and 2032; Figure 6: Gene Editing Technologies Market, Share of Key Developments and Strategies (by Category), January 2018- March 2023; Figure 7: Gene Editing Technologies Market: Research Methodology; Figure 8: Primary Research Methodology; Figure 9: Bottom-Up Approach (Segment-Wise Analysis); Figure 10: Top-Down Approach (Segment-Wise Analysis); Figure 11: Gene Editing Technologies Market: Market Overview; Figure 12: Gene Editing Technologies Market, Potential Forecast Scenarios, 2022-2032; Figure 13: Gene Editing Technologies Market Size and Growth Potential (Realistic Scenario), $Million, 2022-2032; Figure 14: Gene Editing Technologies Market Size and Growth Potential (Optimistic Scenario), $Million, 2022-2032; Figure 15: Gene Editing Technologies Market Size and Growth Potential (Pessimistic Scenario), $Million, 2022-2032; Figure 16: Evolution of Gene Editing Technologies, 1994-2020; Figure 17: Clinical Trial Authorization for Gene Editing; Figure 18: Steps for Obtaining Marketing Authorization; Figure 19: EMA Review Timeline; Figure 20: Comparison of Various Gene Editing Technologies; Figure 21: Gene Editing Technologies Market, Technology Adoption Matrix; Figure 22: Key Strategies Adopted by Major Players, January 2018- March 2023; Figure 23: Gene Editing Technologies Market, Patent Analysis (by Year), January 2018- December 2022; Figure 24: Gene Editing Technologies Market, Patent Analysis (by Technology), January 2018- December 2022; Figure 25: Gene Editing Technologies Market, Patent Analysis (by Region), January 2018- December 2022; Figure 26: Gene Editing Technologies Market, Patent Analysis (by Country), January 2018- December 2022; Figure 27: Gene Editing Technologies Market (by Region); Figure 28: Europe: Market Dynamics; Figure 29: Europe Gene Editing Technologies Market, $Billion, 2022-2032; Figure 30: Europe Gene Editing Technologies Market (by Application), $Billion, 2022-2032; Figure 31: Europe Gene Editing Technologies Market (by Technology), $Billion, 2022-2032; Figure 32: Germany Gene Editing Technologies Market, $Million, 2022-2032; Figure 33: Germany Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 34: Germany Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 35: U.K. Gene Editing Technologies Market, $Million, 2022-2032; Figure 36: U.K. Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 37: U.K. Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 38: Switzerland Gene Editing Technologies Market, $Million, 2022-2032; Figure 39: Switzerland Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 40: Switzerland Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 41: France Gene Editing Technologies Market, $Million, 2022-2032; Figure 42: France Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 43: France Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 44: Spain Gene Editing Technologies Market, $Million, 2022-2032; Figure 45: Spain Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 46: Spain Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 47: Italy Gene Editing Technologies Market, $Million, 2022-2032; Figure 48: Italy Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 49: Italy Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 50: Rest-of-Europe Gene Editing Technologies Market, $Million, 2022-2032; Figure 51: Rest-of-Europe Gene Editing Technologies Market (by Application), $Million, 2022-2032; Figure 52: Rest-of-Europe Gene Editing Technologies Market (by Technology), $Million, 2022-2032; Figure 53: BRAIN Biotech AG: Product Portfolio; Figure 54: BRAIN Biotech AG: Overall Financials, $Million, 2020-2022; Figure 55: BRAIN Biotech AG: Revenue (by Segment), $Million, 2020-2022; Figure 56: BRAIN Biotech AG: Revenue (by Region), $Million, 2020-2022; Figure 57: BRAIN Biotech AG: R&D Expenditure, $Million, 2020-2022; Figure 58: Cellectis S.A.: Product Portfolio; Figure 59: Cellectis S.A.: Overall Financials, $Million, 2020-2022; Figure 60: Cellectis S.A.: R&D Expenditure, $Million, 2020-2022; Figure 61: CRISPR Therapeutics AG: Product Portfolio; Figure 62: CRISPR Therapeutics AG: Overall Financials, $Million, 2020-2022; Figure 63: CRISPR Therapeutics AG: R&D Expenditure, $Million, 2020-2022; Figure 64: DNA Script: Product Portfolio; Figure 65: Magento, Inc.: Product Portfolio; Figure 66: Merck KGaA: Product Portfolio; Figure 67: Merck KGaA: Overall Financials, $Million, 2020-2022; Figure 68: Merck KGaA: Revenue (by Segment), $Million, 2020-2022; Figure 69: Merck KGaA: Revenue (by Region), $Million, 2020-2022; Figure 70: Merck KGaA: R&D Expenditure, $Million, 2020-2022
List of Tables: Table 1: Key Questions Answered in the Report; Table 2: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios; Table 3: Some of the Ongoing Clinical Trials Utilizing Various Gene Editing Technologies; Table 4: Expedited Regulatory Designations Around the World; Table 5: Gene Editing Technologies Market, Product Benchmarking (by Technology)